Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M508118200 on August 15, 2005

J. Biol. Chem., Vol. 280, Issue 40, 33909-33916, October 7, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/40/33909    most recent
M508118200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, J.-C.
Right arrow Articles by Schuler, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, J.-C.
Right arrow Articles by Schuler, L. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Proteasomes Mediate Prolactin-induced Receptor Down-regulation and Fragment Generation in Breast Cancer Cells*

Juu-Chin Lu{ddagger}§12, Timothy M. Piazza{ddagger}1, and Linda A. Schuler{ddagger}§¶3

From the {ddagger}Department of Comparative Biosciences, §Endocrinology-Reproductive Physiology Program, and Comparative Biomedical Sciences Program, University of Wisconsin-Madison, Wisconsin 53706

Prolactin regulates a variety of physiological processes, including mammary gland growth and differentiation, and recent findings support an important role in breast cancer development and progression. However, little is known about the trafficking of its receptor, a member of the cytokine receptor superfamily. In the present study, we examined the effect of ligand on the endogenous "long" isoform of the prolactin receptor in breast cancer cells. We found that prolactin caused rapid and prolonged down-regulation of this receptor. The prolactin-induced increase in degradation was blocked by inhibitors of both proteasomes and lysosomes. However, the ubiquitin-conjugating system was not required for internalization. Prolactin also resulted in the concomitant appearance of a cell-associated prolactin receptor fragment containing the extracellular domain. This latter process required proteasomal, but not metalloprotease, activity, distinguishing it from ectodomain "shedding" of other membrane receptors, which are secreted as binding proteins. The prolactin receptor fragment was labeled by surface biotinylation and independent of protein synthesis. Together, these data indicated that prolactin binding initiates limited proteasomal cleavage of its receptor, generating a cell-associated fragment containing the extracellular domain. Our findings described a new potential mediator of prolactin action and a novel mechanism whereby proteasomes modulate cellular processes.


Received for publication, July 25, 2005

* This work was supported in part by National Institutes of Health R01 CA78312 and R01 DK62783, the University of Wisconsin Center for Women's Health and Women's Health Research and the University of Wisconsin School of Veterinary Medicine. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

2 Present address: Division of Endocrinology and Metabolism, Dept. of Medicine, University of California, San Diego, CA 92093.

3 To whom correspondence should be addressed: Dept. of Comparative Biosciences, University of Wisconsin, 2015 Linden Dr., Madison, WI 53706. Tel.: 608-263-9825; Fax: 608-263-3926; E-mail: schulerl{at}svm.vetmed.wisc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
T. M. Piazza, J.-C. Lu, K. C. Carver, and L. A. Schuler
Src Family Kinases Accelerate Prolactin Receptor Internalization, Modulating Trafficking and Signaling in Breast Cancer Cells
Mol. Endocrinol., February 1, 2009; 23(2): 202 - 212.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
B. Varghese, H. Barriere, C. J. Carbone, A. Banerjee, G. Swaminathan, A. Plotnikov, P. Xu, J. Peng, V. Goffin, G. L. Lukacs, et al.
Polyubiquitination of Prolactin Receptor Stimulates Its Internalization, Postinternalization Sorting, and Degradation via the Lysosomal Pathway
Mol. Cell. Biol., September 1, 2008; 28(17): 5275 - 5287.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
E. A. Dunlop, A. P. Maxwell, and T. R.J. Lappin
Impaired Downregulation Following Erythropoietin Receptor Activation in Non-Small Cell Lung Carcinoma
Stem Cells, February 1, 2007; 25(2): 380 - 384.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. L. Gadd and C. V. Clevenger
Ligand-Independent Dimerization of the Human Prolactin Receptor Isoforms: Functional Implications
Mol. Endocrinol., November 1, 2006; 20(11): 2734 - 2746.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement